Early Access — free while we kick the tires
EdgarHawk

RNTX Rein Therapeutics, Inc. Insider Trading

Latest: Director Bought $50K of Shares · May 2026
1 filing analyzed · Latest 2026-05-28
Insider buys
1
Insider sells
0
Unique insiders
1
Direction
Net buying
May 2026
2026-05-28
high
Rickenbach Josef H Von Buy
47,060 shares
$49,561
@ $1.05
Significance 6/10

Director Von Rickenbach purchases 47,060 shares at $1.04–$1.07 (avg $1.05), tripling holdings to 62.5K shares amid -49.8% drawdown from 52-week high.

Rickenbach Josef H Von, a Director at unprofitable RNTX, executed 4 separate purchases totaling 47,060 shares for $49,560.64 between May 21–27, 2026, at prices ranging from $1.04 to $1.07. This increased his holdings by 304.5% from 15,454 to 62,514 shares. The stock is currently trading at $1.11, representing a -49.8% decline from its 52-week high of $2.21 and a -23.4% drop over the prior 30 days. The company posted $0.00 quarterly revenue and -$5.8M net income, with negative full-year profitability. The magnitude of the purchase relative to prior holdings and the execution across multiple trading days warrants attention to whether this reflects a strategic reassessment or other material considerations.

More Chemicals and Allied Products companies

Get alerts for RNTX

Add RNTX to your watchlist and we'll email you when an insider files a Form 4 — with our AI's significance score and a plain-English read of what it means.

Sign up — free during early access